BEIJING, Feb. 21, 2014 (GLOBE NEWSWIRE) -- Dehaier Medical Systems Ltd. (Nasdaq:DHRM) (“Dehaier” or the “Company”), an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in China, today announced that it entered into a securities purchase agreement (the “Securities Purchase Agreement”) with certain institutional investors for the sale of 737,700 common shares in a registered offering at the price of $9.12 per common share. After payment of expenses, the Company will receive approximately $6.1 million in net proceeds. In addition, warrants to purchase 220,410 common shares in the aggregate will be issued to the investors. If fully exercised, the Company would receive aggregate gross proceeds from the warrants of approximately $2.6 million.
Help employers find you! Check out all the jobs and post your resume.
